tiprankstipranks
Trending News
More News >
Syros Pharmaceuticals (SYRS)
OTHER OTC:SYRS
US Market

Syros Pharmaceuticals (SYRS) Income Statement

Compare
1,071 Followers

Syros Pharmaceuticals Income Statement

Last quarter (Q3 2024), Syros Pharmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Syros Pharmaceuticals's net income was $-6.40M. See Syros Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 9.94M$ 14.88M$ 23.49M$ 15.09M$ 1.98M
Gross Profit
$ 7.68M$ 11.91M$ 23.49M$ 15.09M$ 1.98M
Operating Expenses
$ 30.77M$ 38.81M$ 122.91M$ 97.39M$ 79.72M
Depreciation and Amortization
$ 2.25M$ 2.97M$ 3.02M$ 3.04M$ 2.72M
EBITDA
$ -157.19M$ -87.55M$ -79.63M$ -79.21M$ -72.72M
Operating Income
$ -128.99M$ -135.87M$ -99.42M$ -82.30M$ -77.74M
Other Income/Expenses
$ -35.59M$ 41.22M$ 12.86M$ -1.74M$ 2.30M
Pretax Income
$ -164.57M$ -94.65M$ -86.56M$ -84.04M$ -75.44M
Net Income
$ -164.57M$ -94.65M$ -86.56M$ -84.04M$ -75.44M
Per Share Metrics
Basic EPS
$ -5.81$ -7.49$ -13.84$ -18.25$ -18.76
Diluted EPS
$ -5.81$ -7.49$ -13.84$ -18.25$ -18.76
Weighted Average Shares Outstanding
28.33M 12.63M 6.25M 4.61M 4.02M
Weighted Average Shares Outstanding (Diluted)
28.33M 12.63M 6.25M 4.61M 4.02M
Currency in USD

Syros Pharmaceuticals Earnings and Revenue History